Clinical trial

Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN

NCT02940327

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-02-19

PhaseN/A

Conditions

Persistent Pulmonary Hypertension of the Newbornverified · MONDO: persistent fetal circulation syndrome

Interventions

Sponsors & collaborators

University of Leicesterlead sponsor

University Hospitals, Leicestercollaborator

Heart Link Children's Charitycollaborator

British Heart Foundationcollaborator

Mapped research locations

LeicesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02940327 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.